Chemical Science · 2017 · 197 citations · 42 references
PharmacyOncologyPharmacologyCancer PharmacologyChemotherapyDrug DeliveryCancer Drug DeliveryCancer NanomedicineDrug Delivery EngineeringDrug Delivery SystemsNanocarriers For TherapeuticsPh-responsive Drug DeliveryAnticancer ActivityAnticancer ChemotherapyChemotherapy DeliveryDrug Delivery NanocarriersOxaliplatin-based TherapyPh-responsive DeliveryTumor SelectivityTumor-targeted Drug Delivery
A responsive drug delivery system (DDS) for oxaliplatin (<bold>OX</bold>) has been designed with a view to overcoming several common drawbacks associated with this widely used anticancer agent, including fast degradation/deactivation in the blood stream, lack of tumor selectivity, and low bioavailability.
42
Platinum Compounds: a New Class of Potent Antitumour Agents
Barnett Rosenberg, Loretta Vancamp, James E. Trosko et al. · Nature · 1969 · 3.9K citations
Pillararenes, A New Class of Macrocycles for Supramolecular Chemistry
Min Xue, Yong Yang, Xiaodong Chi et al. · Accounts of Chemical Research · 2012 · 1.4K citations